Recently, the Class 1 innovative drug Pradefovir Mesylate Tablets (trade name: 新舒沐) of Xi'an Gelan Xintong Pharmaceutical Co., Ltd. is approved for marketing by China NMPA. This drug is indicated for the treatment of adult patients with chronic hepatitis B, providing a new treatment option for patients.